Ameriprise
TNGX icon

Ameriprise’s Tango Therapeutics TNGX Stock Holding History

Ameriprise’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Buy
+506,158
New +$7.05M ﹤0.01% 1881
2025
Q2 		– Sell
-82,657
Closed -$113K – 4125
2025
Q1 		$113K Buy
82,657
+71,459
+638% +$176K ﹤0.01% 3865
2024
Q4 		$34.6K Buy
+11,198
New +$52K ﹤0.01% 4029
2023
Q4 		– Sell
-12,715
Closed -$143K – 3977
2023
Q3 		$143K Sell
12,715
-38,544
-75% -$235K ﹤0.01% 3744
2023
Q2 		$170K Sell
51,259
-1,185
-2% -$4.26K ﹤0.01% 3750
2023
Q1 		$207K Buy
52,444
+24,434
+87% +$142K ﹤0.01% 3722
2022
Q4 		$203K Buy
28,010
+10
+0% +$70 ﹤0.01% 3701
2022
Q3 		$101K Buy
+28,000
New +$120K ﹤0.01% 3829

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return